Trial Details

COMPLETED
Basic Information
Clinical ID c439
Identifier NCT02712866
Trial Title Early Biomarkers in Circulating 47 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Inflammatory Bowel Disease
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Parc de Salut Mar
City Barcelona
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-01-17
Primary Completion Date 2025-02-19
Completion Date 2025-02-19